National Health Investors (NYSE:NHI) Updates FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.430-4.440 for the period, compared to the consensus EPS estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Price Performance

National Health Investors stock traded up $0.81 during mid-day trading on Tuesday, hitting $76.73. The company’s stock had a trading volume of 340,584 shares, compared to its average volume of 190,436. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $3.33 billion, a P/E ratio of 26.00, a P/E/G ratio of 5.09 and a beta of 1.05. The stock’s fifty day moving average price is $80.53 and its two-hundred day moving average price is $73.03. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). The firm had revenue of $84.97 million during the quarter, compared to analysts’ expectations of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business’s revenue was up 9.1% on a year-over-year basis. During the same period last year, the business earned $1.06 earnings per share. Research analysts forecast that National Health Investors will post 4.48 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on NHI shares. Bank of America assumed coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target for the company. Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Finally, Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.